Detection of Urinary Biomarkers: From Current to Future Challenges
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".
Deadline for manuscript submissions: closed (30 November 2023) | Viewed by 169
Special Issue Editor
Special Issue Information
Dear Colleagues,
The need for sensitive tests to detect early kidney disease and damage remains a high priority. The kidney is particularly susceptible because of its high blood supply and transcellular transport system. Over the last 50 years, a variety of biomarkers of effect, progression and prognosis have been identified. Biomarkers are used to detect nephrotoxic drugs, industrial and environmental nephrotoxicity and kidney disease in patients and animals. Future work should include the development of point of care devices and improved assay techniques. Biomarkers should be defined in terms of the stage of renal damage/disease they reflect. As improvement in technology becomes available, these tests will become more widely used, especially in developing countries. This Special Issue contains a summary of the current use of biomarkers and potential development in medicine, industrial areas and the environment, together with details of cutting-edge technology.
Prof. Dr. Robert G. Price
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- diagnostic biomarkers
- acute renal injury
- urinary enzyme biomarkers
- diabetes
- industrial pollution
- chronic kidney disease
- nephrotoxic drugs
- novel assay procedures
- fluorescent procedures
- mRNA biomarkers
- NAG, KIM-1, NGAL
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
